Status:
RECRUITING
Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Conditions:
Breast Cancer
Oncoplastic Breast Surgery
Eligibility:
FEMALE
18+ years
Brief Summary
Breast conserving surgery followed by radiotherapy is the gold standard treatment for early breast cancer. Cases with unfavorable tumor volume to breast volume ratio or challenging localizations are a...
Eligibility Criteria
Inclusion
- Patients treated with BCS combined with CWPFs for primary stage I-III invasive cancer (IC) or ductal carcinoma in situ (DCIS);
- Patients treated during the last 10 years (2015-2025);
- Patients aged 18 years or more;
- Cases with at least one-year follow-up.
Exclusion
- Male Patients;
- Patients aged less than 18 years;
- Patients who underwent traditional breast conserving surgery or OBCS with displacement techniques;
- Patients who underwent mastectomy;
- Patients who underwent implant-based reconstruction;
- Patients with unresectable breast cancer or metastatic disease;
- Patients who were lost during follow-up.
Key Trial Info
Start Date :
April 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06906237
Start Date
April 18 2024
End Date
December 1 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Veneto Institute of Oncology
Padua, Italy, 35128